The store will not work correctly when cookies are disabled.
5-Chloro-N-(2-chloro-4-(propylamino)phenyl)-2-hydroxybenzamide
ID: ALA4757265
PubChem CID: 162656559
Max Phase: Preclinical
Molecular Formula: C16H16Cl2N2O2
Molecular Weight: 339.22
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCNc1ccc(NC(=O)c2cc(Cl)ccc2O)c(Cl)c1
Standard InChI: InChI=1S/C16H16Cl2N2O2/c1-2-7-19-11-4-5-14(13(18)9-11)20-16(22)12-8-10(17)3-6-15(12)21/h3-6,8-9,19,21H,2,7H2,1H3,(H,20,22)
Standard InChI Key: LKHHYCQJKRLODE-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
9.9705 -6.6424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2601 -7.0486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5523 -6.6376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8460 -7.0439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8433 -7.8611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5510 -8.2720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2615 -7.8658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9691 -5.8252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6741 -7.0533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5551 -5.8205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3846 -6.6430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0923 -7.0540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7986 -6.6477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8013 -5.8305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0936 -5.4196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3873 -5.8258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5118 -5.4243 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2154 -5.8353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9258 -5.4249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0895 -7.8711 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.5483 -9.0892 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.6336 -5.8334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
3 10 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
18 19 1 0
17 18 1 0
14 17 1 0
12 20 1 0
9 11 1 0
6 21 1 0
19 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 339.22 | Molecular Weight (Monoisotopic): 338.0589 | AlogP: 4.77 | #Rotatable Bonds: 5 |
Polar Surface Area: 61.36 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.39 | CX Basic pKa: 4.54 | CX LogP: 4.32 | CX LogD: 4.02 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.74 | Np Likeness Score: -1.67 |
References
1. Xu J,Berastegui-Cabrera J,Ye N,Carretero-Ledesma M,Pachón-Díaz J,Chen H,Pachón-Ibáñez ME,Sánchez-Céspedes J,Zhou J. (2020) Discovery of Novel Substituted N-(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide Analogues as Potent Human Adenovirus Inhibitors., 63 (21): [PMID:33112138] [10.1021/acs.jmedchem.0c01226] |
2. Xu J, Wu W, Chen H, Xue Y, Bao X, Zhou J.. (2021) Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses., 39 [PMID:33895704] [10.1016/j.bmc.2021.116157] |